Design of a phase 3, prospective, multicenter, open-label study of safety and hemostatic efficacy of rurioctocog alfa pegol in previously untreated patients <6 years of age with severe hemophilia A

被引：0
|
作者：
Mullins, E. [1 ,2 ]
Kefurt, C. [3 ]
Engl, W. [3 ]
Tangada, S. [4 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[3] Shire, Vienna, Austria
[4] Shire, Lexington, MA USA
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P095
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study
    Perez de Llano, Luis A.
    Cosio, Borja G.
    Domingo, Christian
    Urrutia, Isabel
    Bobolea, Irina
    Valero, Antonio
    Entrenas Costa, Luis M.
    Quirce, Santiago
    Barranco, Pilar
    Marina Malanda, Nuria
    Prieto Andres, Luis
    Alvarez-Gutierrez, Francisco J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (07): : 2277 - +
  • [32] Open-label, non-comparative, multicenter, phase III clinical trial for evaluation of efficacy and safety of recombinant factor VIII (Greengene) in previously treated patients with hemophilia A
    Lee, K.
    Park, S.
    Lee, S.
    Kook, H.
    Hwang, T.
    Choi, Y.
    HAEMOPHILIA, 2008, 14 : 93 - 93
  • [33] Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis
    Cork, Michael J.
    Thaci, Diamant
    Eichenfield, Lawrence F.
    Arkwright, Peter D.
    Chen, Zhen
    Thomas, Ryan B.
    Kosloski, Matthew P.
    Dubost-Brama, Ariane
    Prescilla, Randy
    Bansal, Ashish
    Levit, Noah A.
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2697 - 2719
  • [34] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Ito, Shuichi
    Nishiyama, Yuya
    Sugiura, Kenkichi
    Enya, Kazuaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (04) : 350 - 358
  • [35] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [36] Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter study
    Guffon, Nathalie
    Konstantopoulou, Vassiliki
    Hennermann, Julia B.
    Muschol, Nicole
    Bruno, Irene
    Tummolo, Albina
    Ceravolo, Ferdinando
    Zardi, Giulia
    Ballabeni, Andrea
    Lund, Allan
    JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (04) : 705 - 719
  • [37] Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study
    Chang, Young
    Kim, Sang-Gyune
    Jeong, Soung-Won
    Jang, Jae-Young
    Yoo, Jeong-Ju
    Lee, Sae-Hwan
    Kim, Young-Seok
    Kim, Hong-Soo
    Lee, Hyun-Woong
    Park, Suyeon
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [38] Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study
    Cork, M. J.
    Thaci, D.
    Eichenfield, L. F.
    Arkwright, P. D.
    Sun, X.
    Chen, Z.
    Akinlade, B.
    Boklage, S.
    Guillemin, I.
    Kosloski, M. P.
    Kamal, M. A.
    O'Malley, J. T.
    Patel, N.
    Graham, N. M. H.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (05) : 857 - 870
  • [39] Efficacy and Safety of Canakinumab in Patients with CAPS Aged <24 Months: Results from an Open-Label, Multicenter, Phase III Trial
    Brogan, Paul
    Hofer, Michal
    Kuemmerle-Deschner, Jasmin B.
    Lauwerys, Bernard R.
    Speziale, Antonio
    Abrams, K.
    Leon, Karolynn
    Wei, Xiaoling
    Laxer, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [40] A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine in Previously Untreated Patients with TP53-Mutant Acute Myeloid Leukemia
    Daver, Naval
    Vyas, Paresh
    Chao, Mark
    Xing, Guan
    Renard, Camille
    Ramsingh, Giri
    Sallman, David A.
    Wei, Andrew H.
    BLOOD, 2021, 138
12345